FDA Approves Fourth COVID Shot. Fifth Shot Considered.
On Mar. 29, 2022, the U.S. Food and Drug Administration (FDA) approved a second booster dose (a fourth shot) of the Pfizer/BioNTech messenger RNA (mRNA) biologic BNT162b2 (“Comirnaty”) and Moderna/NIAID mRNA-1273 (“Spikevax”) for people 50 years of age and older, as well as younger individuals who are immunocompromised. The second booster would be given no […]
Autoimmune Bleeding Disorder Diagnosed After COVID Shots
Four cases of an autoimmune bleeding disorder known as acquired hemophilia (AHA) were diagnosed in Italy’s northern province of Reggio Emilia weeks after the individuals received Pfizer/BioNTech’s experimental messenger RNA (mRNA) BNT162b2 (also known as “Comirnaty”) biologic. The report about these four cases was published in a letter to the editors of journal Thrombosis Research […]
NIH-Funded Study Found COVID-19 Shots Impact Menstrual Cycles
A U.S. cohort study assessing the effect of COVID-19 shots on menstrual cycles was peer reviewed and published in the journal Obstetrics & Gynecology on Jan. 5, 20221 after many women spoke out about changes to their menstrual cycles after receiving COVID shots. The U.S. National Institutes of Health (NIH) provided $1.6 million to fund […]
Hearing Loss and Tinnitus May Be Linked to COVID Vaccination
A new study published in the journal JAMA Otolaryngology-Head & Neck Surgery published on Feb. 24, 2022 has found a possible association between Pfizer/BioNTech’s BNT162b2 (also known as “Comirnaty”) messenger RNA (mRNA) COVID-19 biologic and sudden sensorineural hearing loss (SSNHL). The retrospective cohort study of 2 ,602, 557 patients in Israel suggested a slight increased risk of SSNHL.1 […]
Myocarditis Risk Following mRNA COVID Shots May Be Far Higher Than Previously Estimated
A new study conducted by researchers from the U.S. Centers for Disease Control and Prevention (CDC) and several universities and hospitals in the United States shows that the risk of myocarditis (inflammation of the heart muscle) after receiving a messenger RNA (mRNA) COVID-19 biologic is 133 times greater than the normal risk for the condition […]
New York Times Deputy Editor Dies of Heart Attack Day After Getting Moderna COVID Shot
The deputy Asia editor for The New York Times, Carlos Tejada, died in a hospital in Seoul, South Korea on Dec. 17, 2021, the day after reportedly getting a booster shot of Moderna/NIAID’s experimental messenger RNA (mRNA) mRNA-1273 (also known as “Spikevax”) biologic.1 2 3 4 According to his wife, 49-year-old Tejada died of a […]
